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Abstract
Background: Identification of the types of strains of Mycobacterium tuberculosis (M. tuberculosis) complex causing
tuberculosis (TB) could contribute to TB control program of specific geographic region as well as it could add
knowledge onto the existing literature on TB worldwide. The objective of the present study was to identify the
species and strains of M. tuberculosis complex causing pulmonary tuberculosis in central Ethiopia.
Methods: A health institution- based cross-sectional study was conducted on 338 smear positive TB cases visiting
three hospitals between October 2012 and September 2013. Morning and spot sputum samples were collected
before the starting of treatment regimens. Thus, a total of 338 pooled sputum samples collected from these cases.
Samples were cultured on Löwenstein Jensen media and the isolates were identified by the region of difference
(RD) 9 based polymerase chain reaction (PCR) and spoligotyping.
Result: Of the total isolates 98.6% of the isolates were identified to be M. tuberculosis while the remaining 1.4%
were identified as M. africanum. Further, typing of M. tuberculosis using spoligotyping lead to the identification of
90 different strains of M. tuberculosis. Of these strains, 32 were clustered consisting of more than one isolate while
the remaining 58 strains were unique consisting of single isolate. Thus, 79.3% (223/281) of the isolates were found
in the clustered while only 20.6% (58/281) of the strains were unique. Forty-five of the spolgotyping patterns were
registeredin the SITVIT2 or SpolDB4 database in while the remaining 45 were notfound in the database and hence
were orphan strains. The dominant strains were SIT53, SIT149, and SIT54, consisting of 43, 37 and 34 isolates,
respectively. Classification of the spoligotype patterns using TB-insight RUN TB-Lineage showed that 86.8, 6.4, 5, 1.
4% ofthe isolatesbelonged to the Euro-American lineage, East-African-Indian, Indo-oceanic and M. africanum,
respectively.
Conclusion: The identification of clustered and new strains using spolygotyping in present study does not give
conclusive finding as spoligotyping has low discriminatory power. Thus, further identification of these isolates using
mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VENTR) and or whole genome
sequencing (WGS) recommended.
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Background
Tuberculosis (TB) is one of an infectious disease, affect-
ing millions of people worldwide. According to the 13th
Annual TB Report in 2014, there were 9.6 million new
TB cases and 1.5 million TB deaths annually [1]. The
spread of human immunodeficiency virus (HIV) and
drug-resistant TB have exacerbated the situation.
Ethiopia has high rate of TB infection and the dis-
ease is one of major public health problems in the
country [2]. According to a WHO report, the country
is one among the world’s 22 countries with high TB
burden [1]. The annual incidence of new TB cases was
estimated to be 207/100,000 and the prevalence of TB
in the country was 200/100,000 [1]. The country is
one of the 27 high MDR-TB countries; ranked 15th
with more than 5000 estimated MDR-TB patients each
year [1, 2]. MDR TB was 1.6% of new cases and 12% of
re-treatment cases [1].
Effective TB control program requires understanding
of its epidemiology including the strains of M.tuberculo-
siscomplex (MTBC) circulating in the population [3].
Molecular epidemiological studies have been used to
provide valuable information onthe spread of tubercle
bacilli in outbreaks [4] and also contributed to study the
transmission dynamics of TB [5]. Moreover, such studies
can help in distinguishing exogenous reinfection from
endogenous reactivation [6]. Additionally, molecular epi-
demiological studiescan be used to identify laboratory
cross contamination [7] and to track the geographic dis-
tribution and spread of clones, including Multi drug re-
sistant strains [8]. Furthermore, molecular typing has
shown the large differences in pathobiological properties
of MTBC species [9].
In Ethiopia, TB is a major public health problem and
few molecular epidemiological studies have been done
so far in some part of the country. While the genetic di-
versity of M. tuberculosis lineages in the country has
been investigated [10–13], there is little or no data in
some part of the country including this study area. The
availability of such information will help study the
phylogenetic characteristics of an organism, which in
turn will provide new insight into the natural history of
M. tuberculosis and Knowledge on the Mycobacterium
tuberculosis strains circulating in the country communi-
ties is useful for epidemiology, transmission, and is es-
sential in the control of the disease.
Thus, identificationthe types of strains of MTBC caus-
ing TB in a specific geographic region could contribute
to the strengthening the TB control program of that
specific geographic region, as it can alert personnel in
the TB Control Program so that they can monitor the
transmission of special strains such as drug resistant
and virulent strains. In addition, identificationthe
types of strains circulating in a specific geographic
region could help in adding additional knowledge on
the existing literature on TB worldwide. To our know-
ledge there is scarcity of information on strains of M.
tuberculosis of circulating in central Ethiopia. There-
fore, the objective of the present study was to identify
the species and strains of MTBC causing pulmonary
TB in central Ethiopia.
Methods
Study area
This study was performed at three different sites in cen-
tral Ethiopia. These sites were Woliso and Atat towns
and their surroundings in the southwest of Addis Ababa
at a distance of 114 km and 187 km, respectively. The
third site was Fiche town and its surrounding in the
northwest of Addis Ababa at 115km. Sample collection
was performed at hospitals located at these three sites,
namely, St. Lukas, Atat and Fitche hospitals located at
Woliso, Atat and Fitche tows, respectively. Sputum sam-
ples were collected from smear positive TB cases visiting
these three hospitals.
Study design and study subjects
A health institution-based cross-sectional study was con-
ducted on 338 smear positive TB patients visiting three
hospitals, between October 2012 and September 2013.
Three consecutive sputum samples (spot, early morning
and spot) were collected from each of these 338 smear
positive TB patient and pooled together for culturing.
Sample collection was performed prior to the beginning
of TB treatment. TB patients less than 18 years old
excluded from this study. Socio-demographic data of the
patients were obtained from the medical records of all
patients.
Those samples positive for acid fast bacilli (AFB) by
Ziehl-Neelsen (ZN) staining technique were collected
labeled and samples from the individual patient pooled
together. These sputum samples for culture were stored
at −20°C and then transported in a cold box (at +4°C) to
Aklilu Lemma Institute of Pathobiology (ALIPB), Addis
Ababa, within a week for culture.
Culture
Morning and spot sputum samples were collected and
processed for culture following the WHO Guideline [14].
Briefly, equal volume of 4% NaOH was mixedwith sputum
sample and the mixture was centrifuged at 3000 rpm for
15 min at room temperature. After decanting the super-
natant the sediment was neutralized with 2 N HClusing
phenol red as an indicator. Neutralization was achieved
when the color of the solution was changed from purple
to yellow. Thereafter, 100 μl of the suspension was inocu-
lated ontotwo sterile LJ medium slopes (which were
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enriched with either pyruvate or glycerol). The inoculated
media were then incubated at 37°C in slanted positionfor
1 week and upright position for 4–5 weeks. The growth of
the bacteria was read every week until the 8thweek of
culture.
Preparation of specimens for molecular typing
Colonies were removed from the surface of LJ medium
and suspended in 200 μl of sterile double distilled water.
Thereafter, the colonies and water were mixed thor-
oughly and then, the mixture was heated at 80°C for 1 h
in water bath. This is followed by centrifugation after
which the supernatant was collected and used for ampli-
fication [15].
Region of difference (RD) 9-based polymerase chain
reaction (PCR)
Identification of M. tuberculosis from the other mem-
bers of M. tuberculosis complexspecies was done using
RD9-based PCR. RD9-PCRwas performed on heat-
killed cells to confirm the presence or absence of RD9
using three primers namely, RD9flankF, RD9 IntR, and
RD9flankR. Amplification was done by standard thermo
cycler (VWR Thermo cycler, UK). The PCR amplification
mixture used consisted of 10 μlHotStarTaqMaster Mix
(Qiagen, United Kingdom), 7.1μl distilled water, 0.3 μl of
each three primers and 2 μl of DNA template(heat killed
cells), giving a total volume of 20 μl. The PCR reaction
was heatedat 95°C for 15 min after which it was subjected
to 35 cycles consisting of 95 °C for one min, 55 °C for one
minutes, and 72 °C for one minute. Thereafter, the reac-
tion mixture was maintained at 72 °C for 10 min following
which the product was removed from the thermocycler
and run on agarose gel electrophoresis. For gel electro-
phoresis, 8 μl PCR products was mixed with 2 μl loading
dye, loaded onto 1.5% agarose gel and electophoresed at
100 V and 500 mA for 45 min. The gel was then visualized
using a computerized Multi- Image Light Cabinet (VWR).
M. tuberculosis H37Rv, M. bovisbacilleCalmette-Guérin,
and water were included as positive and negative controls.
Interpretation of the result was based on bands of differ-
ent sizes, as previously described by Parsons et al. [16].
Spoligotyping
Isolates that were positive for M. tuberculosis by RD9 PCR
were further characterized by spoligotyping following the
procedure described by Kamerbeeket al [17] and by ob-
serving the instructions of the spoligotype kit supplier
(Ocimum Biosolutions Company, Iisselstein, and the
Netherlands). The direct repeat (DR) region of the isolate
was amplified by PCR using oligonucleotide primers (DRa
and DRb) derived from the DR sequence [17]. The ampli-
fied biotinylated products were hybridized to a set of 43
oligonucleotides covalently bound to a membrane (Animal
and Plant Health Agency, Great Britain). Bound fragments
were incubated with streptavidinperoxidase conjugate and
hybridizing DNA was detected by the enhanced chemilu-
minescence method, by exposure to X-ray film (Hyperfilm
ECL, Amersham) as specified by the manufacturer’s in-
struction. The presence and absence of spacers was visual-
ized on the film as black and white squares, respectively.
Characterized strains of M. bovisand M. tuberculosis H37Rv
were used as positive controls, whereas Qiagen distilled
water (Qiagen company, Germany) was used as a negative
control.
Use of SpolDB4 and Run TB-Lineage for the identification
of strains and lineages
The results of spoligotyping were converted into octal
and binary formats. These binary and octal formats of
the strains were entered into query box so that the name
of the strains are retrieved from the database if the spoli-
gotype pattern of the strain in question fits the pattern
that has already been registered in the SPolDB4 database
[18] and at http://www.pasteur-guadeloupe.fr:8081/SIT-
VITDemo/ [10]. If the pattern of the strain in question
has not been registered in SPolDB prior to this study, the
strain was considered as an orphan. In this study, an iso-
late is referred to as a colony that was grown on LJ media
and found to be AFB-positive after staining with Ziehl
Neelsen staining, whereas a strain is an isolate (s) with
specific spoligotype pattern. Thus, a strain can consist of a
single isolate or several isolates. A strain with a single iso-
late is termed as a unique strain while a strain with more
than one isolate is considered as clustered strain. An
Table 1 Background characteristics tuberculosis patients from
whom the M. tuberculosis isolates were obtained









History of anti-tuberculosis treatment
Previously treated 10(3.6)
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online tool Run TB-Lineage http://tbinsight.cs.rpi.edu/
run_tb_lineage.html was also used to predict the major
lineages using a conformal Bayesian network (CBN) ana-
lysis and sub lineage using knowledge based Bayesian net-
work (KBBN).
Statistical analysis
The statistical analysis was performed using STATA
software version 12. Descriptive statistics were used to
depict the demographic variables. Pearson chi-square
was used to evaluate the association between source
Table 2 Description of 45 shared-types (SITs;n= 224 isolates) which have already been registered in the SITVIT2 or SpolDB4 database and
corresponding spoligotyping defined lineages/sublineages starting from a total of 281 M. tuberculosis strains isolated in central Ethiopia
A total of 281 isolates grouped into 90 different spolygotype patterns. Of the 90 spolygtype pattern, 45 were registered in the international database while 45 of the strains
were not found in the database. Of these 90 strains, 32 were clustered strains consisting of 223 (79.3%) isolates while 58 strains were found as single isolate. The
dominantly found strains were SIT 53, SIT 149, and SIT 54 consisting of 43, 37 and 34 isolates, respectively. Classification of the spoligotype patterns using TB-insight RUN
TB-Lineage showed that 86.8%, 6.4%, 5.3%, 1.4% of the isolates belonged to the Euro-American lineage, East-African-Indian, Indo-oceanic and M. africanum, respectively. EA
Euro-American; EAI East-African Indian; IO Indo-Oceanic; MA M. africanum; MB M. bovis; CBN conformal Bayesian network; KBBN knowledge based Bayesian network
Fig. 1 Picture of gel electrophoresis for RD9 deletion typing of M. tuberculosis isolates. Lane 1 is a ladder, lane 2 is M. Tuberculosis control, lane 3
is Negative control (molecular grade H2O), lane 4 is M. bovis control and lane 5–26 is culture isolate of M. Tuberculosis
Bedewi et al. BMC Infectious Diseases  (2017) 17:184 Page 4 of 8
site of the isolate and clustering status of the isolates.
Similarly, Fisher’s exact test was used to test of source-
site is significantly associated with type of major lineage
identified as well as with the type of dominant strain.
Results were considered statistically significant when-
ever p-value was less than 5%.
Result
Demographic characteristics of the study participants
Among 338 smear positive sputa samples297 (87.9%) sam-
ples were confirmed as culture positive. A total of 297M.
tuberculosis isolates were utilized to carry out RD9-PCRand
spoligotyping analysis of which 281 gave valid spolygotyp-
ing data while the remaining 16 isolates did not give any
pattern up on spolygotyping. One hundred thirty (46.2%) of
281 isolates obtained from female while 151 (53.7%) were
isolated from males. Classification of the study participated
on the basis of age showed that 99 (35.3%) were between
18 and 28 years of age, majority (47.7%; 134/281) were orig-
inated from Woliso and its surroundings (Table 1).
Region of difference (RD) 9-based polymerase chain
reaction (PCR). The 281 isolates were analyzed using
RD9 PCR and the result indicated that all isolates had
intact RD9 implying that all the isolates were M. tuber-
culosis (Fig. 1).
Spolygotyping result
Spoligotyping of 281 isolates yielded 90 different spolygo-
type patterns. Of these, 32 strains were clustered containing
of 223 (79.3%) isolates and 58 (20.6%) were unique
strains (Tables 2 and 4). The overall diversity of the iso-
lates was 32.4%. Out of the 90 spolygtype pattern, 45
were registered in the international data base (Table 2)
and the remaining 45 were not found in the database
(Table 3). The dominantly identified strains were
SIT53, SIT149, and SIT 54 consisting of 43 isolates, 37
isolates, 34 isolates, respectively (Table 2). Classification
of the spoligotype patterns using TB-insight RUN TB-
Lineage showed that 86.8, 6.4, 5.3, 1.4% of the isolates
belonged to the Euro-American lineage, East-African-
Table 3 Description of 45 orphan strains (N = 57) and corresponding spoligotyping defined lineages/sublineages recorded among
M. tuberculosis strains starting from a total of 281 M. tuberculosis isolated in central Ethiopia
Of the 90 spolygtype pattern, 45 patters consisting of 57 isolates did not match with the patterns available in the database (orphans)
*CBN: conformal Bayesian network; EA EuroAmerican; IO Indo-Oceanic; EAI East African-Indian; MA M. africanum
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Indian, Indo-oceanic and M. africanum, respectively
(Table 2).
Distribution of strains and lineages in the study area
Of the 281 isolates typed, 134(47.7) were originated
from Woliso and its surroundings, with clustering rate
of 83.6% (112/134), 97(34.5) were originated from Fiche
with clustering rate of 72.2% (70/97). The remaining
isolates were from Atat town with clustering rate of
14.6% (41/281). This finding did not show statistically
significant difference in the proportion of clustering
across the three source sites of the isolates (p-value =
0.163). Similarly, there was not significant association
of the source site of the isolate with major lineage iden-
tified by CBBN (p-value = 0.877) as well as the type of
dominant isolate (p-value = 0.109). The proportions of
occurrence of the dominant lineage (Euro-American) at
Woliso, Fitche and Atat towns were 85.5% (112/131),
89.1%(90/101) and 85.7% (42/49), respectively (Table 4).
Discussion
In the present study, 281 pulmonary TB cases were
recruited from three towns and their surroundings in
central Ethiopia for the isolation and identification of
the species and strains of MTC causing pulmonary TB in
the central Ethiopia. The isolation of was made from the
sputum of patients on LJ medium while RD9-based PCR
and spoligotyping used for identification of the isolates at
the species and strain levels, respectively. An online tool
Run TB-Lineage http://tbinsight.cs.rpi.edu/run_tb_linea-
ge.html was also used for grouping lineages using a con-
formal Bayesian network (CBN) analysis and sub lineage
using knowledge based Bayesian network (KBBN).
Out of the 90 different types of spolygotype patterns,
45 of the patterns which consisting majority of the iso-
lates, matched with the patterns registered in the SIT-
VIT2 database while the remaining 45 patterns did not
match with the patterns registered in the SITVIT2 or
SpolDB4 database. Similar studies that have been con-
ducted in Ethiopia, and thus all the geographic regions
of the country have not been covered and as a result all
the circulating strains of M. tuberculosis have not yet
been registered to the SITVIT2 database. Over 75% of
the isolates were clustered strains with varies sizes of
clustering while about a quarter of the isolates were
found as unique strains. There are various assumptions
with regard to such findings. Although spoligotyping
has less discriminatory power in classifying strains, the
finding of many isolates clustering in the same pattern
could suggest the presence an on-going transmission of
M. tuberculosis infection in the specific geographic re-
gion. On the other hand, the isolation of many unique
strains could suggest the introduction of new strains
into that specific region and these strains did not
spread in that specific geographic region.
Similar to this study, SIT54 was dominantly isolated by
earlier studies conducted in the Addis Ababa City (17),
central Ethiopia (18) and in eastern central Ethiopia (19).
This strain has been mainly reported to the SITVIT2 and
SpolDB4 databasefrom South and East Asia, Middle East
including Egypt and USA [10, 18]. Another interesting
finding in the study was, similar to other studies con-
ducted in Ethiopia earlier [11, 13] the ancestor strain SIT
523 was found consisting of good numbers of isolates. SIT
523 is characterized by the presence of all 43 spacers and
is the ancestor strain of M. tuberculosis. It is less likely that
strains keep all the 43 spacers intact for a long duration of
time since they have to adapt to different pressures
through changing their genetic makeup, and hence it is
likely that the presence of 43 spacers intact could also be
due to mixed infection, which needs further investigation
using more powerful molecular techniques.
The M. tuberculosis isolated by the present study
were belonged to four major lineages including the
Euro-American, East-African-Indian, Indo-oceanic and
the M. africanum. The dominant Lineage wasEuro-
American Lineage consisting 86.8% of the isolates. This
finding is in agreement with the earlier studies [11, 12, 19]
conducted in different regions of Ethiopia. The 2nd and
3rd lineages under which the isolates grouped were East-
African-Indian and Indo-oceanic lineage, respectively.
Four isolates belonged to M. africanum Lineage. M.
africanum has been reported to be an important cause of
Table 4 Distribution of strains and clustering rate in the Study
Area (N = 281)
Characteristics of the
isolates




Total spolygotyped isolates 134 (47.7) 50 (17.8) 97 (34.5)
Clustered isolates versus single
Clustered 112 41 70 0.163
Single 22 9 27
Clustering rate 83.6% 82% 72.2%
Major lineage by CBBN
EA 115 43 86 0.877
EAI 10 4 4
IO 7 2 6
MA 2 1 1
The three dominant Strains
SIT 53 19 6 18 0.109
SIT 149 17 9 11
SIT 54 21 8 5
Orphan strains 21 10 26
EA Euro-American, EAI East-African Indian, IO Indo-Oceanic, MA M. africanum,
MB Mbovis, CBN conformal Bayesian network
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human TB in the west African countries including
Guinea- Bissau [20], the Gambia [21], Sierra Leone [22],
Senegal [23], Burkina Faso [24], Cameroon [25], Nigeria
[26], and CôteD’Ivoire [27].
The limitation of this study is the use of only spoligo-
typing for typing of the isolates. Since the discriminatory
power of spoligotyping is low, the finding of this study
could lead to an overestimation of clustering because of
the failure to differentiate between recent transmissions
and mixed infections. In contrast to spoligotyping, MIRU-
VNTR or WGS genotyping allow for a high-resolution
and discrimination of the isolates for epidemiological
studies and a valid phylogenetic strain classification
[28–30].
Conclusion
The identification of clustered and new strains using
spolygotyping in present study could not give conclusive
report, as spoligotyping has low discriminatory power.
Hence, further characterization of these isolates using
MIRU-VNTR or WGS was recommended.
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